Sinovac Biotech Ltd (SVA) — Capital Reinvestment Ratio
Latest as of December 2023:
0.36x
Sinovac Biotech Ltd (SVA) has a Capital Reinvestment Ratio of 0.36x as of December 2023, meaning it reinvests 0% of its operating cash flow ($146.01 Million) in capital expenditures ($52.75 Million). See SVA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.36x
Capex / Operating Cash Flow
Operating Cash Flow
$146.01 Million
USD
Capital Expenditures
$52.75 Million
USD
Data as of
Dec 2023
Most recent filing
Sinovac Biotech Ltd Capital Reinvestment Ratio (2007–2023)
This chart tracks Sinovac Biotech Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Sinovac Biotech Ltd (2007–2023)
Year-by-year Capital Reinvestment Ratio for Sinovac Biotech Ltd from 2007 to 2023. For live market cap and broader valuation context, see market cap of Sinovac Biotech Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.37x | $106.02 Million | $145.69 Million | ▲ +2830.3% |
| 2021 | 0.05x | $15.35 Billion | $719.98 Million | ▼ -82.4% |
| 2020 | 0.27x | $479.31 Million | $127.65 Million | ▼ -2.1% |
| 2019 | 0.27x | $39.07 Million | $10.63 Million | ▼ -61.5% |
| 2018 | 0.71x | $7.94 Million | $5.61 Million | ▲ +254.4% |
| 2017 | 0.20x | $59.76 Million | $11.91 Million | ▼ -84.2% |
| 2015 | 1.26x | $4.21 Million | $5.30 Million | ▲ +36.7% |
| 2013 | 0.92x | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $4.32 Million | $2.47 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow